These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34601319)

  • 1. Targeting the Nod-like receptor protein 3 Inflammasome with inhibitor MCC950 rescues lipopolysaccharide-induced inhibition of osteogenesis in Human periodontal ligament cells.
    Peng W; Zhang B; Sun Z; Zhang M; Guo L
    Arch Oral Biol; 2021 Nov; 131():105269. PubMed ID: 34601319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GNAI3 mediated by Lin28A regulates lipopolysaccharide-induced inflammation and osteogenic differentiation in periodontal stem cells by mediating the NF-κB/NLRP3 inflammasome pathway.
    Guo L; Sun H; Pu J
    Arch Oral Biol; 2024 Jul; 163():105974. PubMed ID: 38636252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium ion attenuates lipopolysaccharide-stimulated proinflammatory cytokine expression and lipopolysaccharide-inhibited early osteogenic differentiation of human periodontal ligament cells.
    Wei L; Jiang Y; Zhou W; Liu S; Liu Y; Rausch-Fan X; Liu Z
    J Periodontal Res; 2018 Dec; 53(6):999-1008. PubMed ID: 30221352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIPUS inhibited the expression of inflammatory factors and promoted the osteogenic differentiation capacity of hPDLCs by inhibiting the NF-κB signaling pathway.
    Liu S; Zhou M; Li J; Hu B; Jiang D; Huang H; Song J
    J Periodontal Res; 2020 Jan; 55(1):125-140. PubMed ID: 31541455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke.
    Ismael S; Zhao L; Nasoohi S; Ishrat T
    Sci Rep; 2018 Apr; 8(1):5971. PubMed ID: 29654318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated ATF1 Promotes Lipopolysaccharide Induced Inflammatory Response and Inhibits Osteogenic Differentiation of Human Periodontal Ligament Cells by Regulating NF-κB Pathway.
    Guo W; Yan S; Zhao G
    Discov Med; 2024 Mar; 36(182):518-526. PubMed ID: 38531792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of combination of anakinra and MCC950 against acute lung injury is achieved through suppression of the NF-κB-mediated-MAPK and NLRP3-caspase pathways.
    Wang X; Chen S; Zhao L; Shi X
    Int Immunopharmacol; 2021 Aug; 97():107506. PubMed ID: 34022766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin inhibits lipoplysaccharide-induced inflammation and promotes osteogenesis in hPDLCs.
    Wu HH; Guo Y; Pu YF; Tang ZH
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33616153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.
    Vande Walle L; Stowe IB; Šácha P; Lee BL; Demon D; Fossoul A; Van Hauwermeiren F; Saavedra PHV; Šimon P; Šubrt V; Kostka L; Stivala CE; Pham VC; Staben ST; Yamazoe S; Konvalinka J; Kayagaki N; Lamkanfi M
    PLoS Biol; 2019 Sep; 17(9):e3000354. PubMed ID: 31525186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation.
    Yaw ACK; Chan EWL; Yap JKY; Mai CW
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2219-2229. PubMed ID: 32507974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
    Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
    Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model.
    Zhang W; Ba G; Tang R; Li M; Lin H
    Int Immunopharmacol; 2020 Jun; 83():106394. PubMed ID: 32193102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages.
    Finucane OM; Sugrue J; Rubio-Araiz A; Guillot-Sestier MV; Lynch MA
    Sci Rep; 2019 Mar; 9(1):4034. PubMed ID: 30858427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice.
    Wang L; Lei W; Zhang S; Yao L
    Bioorg Med Chem; 2021 Jan; 30():115954. PubMed ID: 33360197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats.
    Luo Y; Lu J; Ruan W; Guo X; Chen S
    Brain Res Bull; 2019 Mar; 146():320-326. PubMed ID: 30716395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oridonin alleviates the inhibitory effect of lipopolysaccharide on the proliferation and osteogenic potential of periodontal ligament stem cells by inhibiting endoplasmic reticulum stress and NF-κB/NLRP3 inflammasome signaling.
    Jiang J; Zhang N; Song H; Yang Y; Li J; Hu X
    BMC Oral Health; 2023 Mar; 23(1):137. PubMed ID: 36894905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome.
    Li H; Guan Y; Liang B; Ding P; Hou X; Wei W; Ma Y
    Eur J Pharmacol; 2022 Aug; 928():175091. PubMed ID: 35714692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation.
    Jiang M; Li R; Lyu J; Li X; Wang W; Wang Z; Sheng H; Zhang W; Karhausen J; Yang W
    J Neuroinflammation; 2020 Aug; 17(1):256. PubMed ID: 32867797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
    Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
    J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.